FDA approves Talicia for H. pylori treatment
by Press Release from Outbreak News Today on (#4TQJQ)
Specialty biopharmaceutical company, RedHill Biopharma Ltd announced that the U.S. Food and Drug Administration (FDA) has approved Talicia(R) (omeprazole magnesium, amoxicillin and rifabutin) delayed-release capsules 10 mg/250 mg/12.5 mg for the treatment of Helicobacter pylori (H. pylori) infection in adults. Talicia is the only rifabutin-based therapy approved for the treatment of H. pylori infection and is designed to address the ["]
The post FDA approves Talicia for H. pylori treatment appeared first on Outbreak News Today.